Brief: Regulus Therapeutics Posts Q3 Loss Per Share Of $0.10
10/11/2021 22:19
Nov 10 (Reuters) - Regulus Therapeutics Inc RGLS.O :
* REGULUS THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND RECENT UPDATES
* Q3 LOSS PER SHARE $0.10
Source text for Eikon: ID:nPn75R7wRa
Further company coverage: RGLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Regulus Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Regulus Therapeutics
Brief: Novartis Announces Expiration Of Hart-Scott-Rodino Waiting Period Of Regulus Therapeutics Tender Offer
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Regulus Therapeutics
Regulus Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Regulus Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview